THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 95 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 28.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,335,000 | -28.0% | 265,459 | 0.0% | 0.02% | -30.4% |
Q1 2019 | $6,018,000 | -11.4% | 265,459 | 0.0% | 0.02% | -20.7% |
Q4 2018 | $6,793,000 | -21.7% | 265,459 | 0.0% | 0.03% | -9.4% |
Q3 2018 | $8,673,000 | +44.0% | 265,459 | 0.0% | 0.03% | +39.1% |
Q2 2018 | $6,021,000 | +10.1% | 265,459 | +17.7% | 0.02% | +9.5% |
Q1 2018 | $5,467,000 | -13.1% | 225,459 | 0.0% | 0.02% | -12.5% |
Q4 2017 | $6,288,000 | +14.5% | 225,459 | +40.5% | 0.02% | +9.1% |
Q3 2017 | $5,494,000 | -14.1% | 160,459 | 0.0% | 0.02% | -15.4% |
Q2 2017 | $6,393,000 | +8.2% | 160,459 | 0.0% | 0.03% | +4.0% |
Q1 2017 | $5,908,000 | +15.5% | 160,459 | 0.0% | 0.02% | +13.6% |
Q4 2016 | $5,115,000 | -12.0% | 160,459 | 0.0% | 0.02% | -12.0% |
Q3 2016 | $5,815,000 | +59.7% | 160,459 | 0.0% | 0.02% | +47.1% |
Q2 2016 | $3,641,000 | +20.7% | 160,459 | 0.0% | 0.02% | +21.4% |
Q1 2016 | $3,017,000 | -42.6% | 160,459 | -50.0% | 0.01% | +27.3% |
Q4 2015 | $5,260,000 | +198.4% | 320,918 | +100.0% | 0.01% | +57.1% |
Q3 2015 | $1,763,000 | +8.0% | 160,459 | +27.9% | 0.01% | +16.7% |
Q2 2015 | $1,633,000 | -25.0% | 125,459 | 0.0% | 0.01% | -25.0% |
Q1 2015 | $2,177,000 | +16.3% | 125,459 | 0.0% | 0.01% | +14.3% |
Q4 2014 | $1,872,000 | -35.3% | 125,459 | 0.0% | 0.01% | -36.4% |
Q3 2014 | $2,892,000 | -27.7% | 125,459 | 0.0% | 0.01% | -31.2% |
Q2 2014 | $4,000,000 | – | 125,459 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |